Raising venture capital can accelerate a company's growth. It can also fundamentally change how that company operates, the expectations placed on its founders, and the decisions required to achieve long-term success.
Few founders understand those tradeoffs better than Luke Bonney, co-founder and CEO of Redox, the healthcare interoperability company that has raised more than $100 million and grown to serve hundreds of customers and thousands of healthcare facilities. Today, Luke coaches founders and CEOs.
During a HealthX founder bootcamp, Luke shared lessons from building Redox through multiple stages of growth and fundraising. His perspective went well beyond the mechanics of raising capital, exploring the strategic decisions that shape a company's trajectory long after a round closes.
In the first article of this series, we explored eight of Luke's practical lessons for executing a successful fundraise. Here, we turn to the bigger picture: determining whether venture capital is the right path, building a credible strategy for growth, learning from investor feedback, and developing a company capable of scaling beyond its earliest days.
Here are seven lessons for founders navigating the venture-backed journey.
1. Decide whether venture capital is truly right for the company
Before building a pitch deck or contacting investors, founders should answer a more fundamental question: Does this company need venture capital?
Venture backing is not an automatic milestone for every technology company. It is a financing model designed for companies pursuing outcomes large enough to justify substantial investment and the return expectations that accompany it.
Luke suggested considering two dimensions of the problem:
How large could the company ultimately become?
If the opportunity is significant, how quickly will others attempt to solve it?
For Redox, the healthcare interoperability problem was both enormous and urgent. Luke and his co-founders believed that if they did not build a better approach, someone else would eventually address the problem, potentially in a way that fell short of what healthcare organizations and patients needed.
That conviction helped justify raising outside capital to move faster than the company could have grown through bootstrapping alone.
The relevant question is not whether venture funding is inherently good or bad. It is whether the company’s vision and market opportunity warrant investing millions of dollars in pursuit of an outcome that could return many times that amount.
2. Understand what accepting investment changes
When founders accept professional investment and establish a board, they are not merely adding money to a bank account. They are changing the governance of the company.
A founding CEO can ultimately be replaced. That reality makes mindset important from the beginning. Founders must decide whether they are building the company primarily to preserve their own position or whether they are in service to solving the problem.
A company with a meaningful mission should eventually be capable of existing beyond any single founder or executive. Accepting that possibility does not diminish the founder’s contribution. It helps keep decisions centered on what the company needs to achieve its full potential.
The same principle applies to dilution. Founders can become so focused on protecting their ownership percentage that they lose sight of the value being created.
A smaller percentage of a large, successful company may be far more valuable than a large percentage of a company that never receives the resources required to grow.
3. Give investors a believable path to scale
A compelling pitch cannot rely on vision alone. Investors need to understand how the company can build a very large business and what evidence suggests that path is achievable.
Luke originally framed this as $100 million in revenue; today he’d say the bar is higher. That does not mean pretending every detail is already known. It means showing the mechanisms through which the company can scale.
Potential growth mechanisms include:
Land-and-expand opportunities within existing customers
Increasing contract value through additional products
Network effects
Channel partnerships
Expansion into adjacent customer segments
New products for the same buyer
Enterprise contracts that materially change the revenue model
Customer relationships that make future customer acquisition easier
A plan that depends entirely on hiring salespeople at the same linear rate as revenue growth may raise questions about the underlying product strategy.
The narrative should explain not just how the company will sell more, but how growth can become more efficient, repeatable, and defensible over time.
4. Match the story to the company’s stage
The fundraising story should evolve as the company matures.
At the earliest stage, founders are primarily asking investors to believe that:
The problem is significant
The team has unusual insight
The proposed approach is differentiated
The founders are capable of learning quickly
The next stage is about repeatability:
Are customers buying a consistent product?
Is there evidence of product-market fit?
Is the company building a product business rather than an unscalable collection of services?
The next phase is scale:
Can the company move from a handful of customers to dozens or hundreds?
Is the go-to-market motion repeatable?
Are the economics improving?
Can the company support a larger organization?
Later, the company may need to address the limits of its initial market and explain how it will expand through new products, new customer segments, or compounding growth mechanisms.
Founders should avoid moving from one product to many before the business requires it. Expanding too early increases operational complexity and can dilute focus. But when the initial market cannot support the company’s long-term ambitions, a credible adjacency strategy becomes essential.
5. Let fundraising feedback inform company strategy
If investors consistently struggle to understand or believe the company’s growth narrative, the problem may not be the presentation. It may be the strategy.
Fundraising forces founders to answer difficult questions:
Is the market sufficiently large?
Can the company scale without proportionally increasing headcount?
Is there a repeatable growth engine?
Does the product create durable differentiation?
Are there credible expansion opportunities?
What must be true for the company to achieve venture-scale outcomes?
A weak narrative can reveal gaps in the business model, product roadmap, or go-to-market strategy.
That does not mean founders should reshape the company around every investor comment. Investors can be wrong, and their views may conflict. But patterns in the feedback deserve attention.
The best fundraising processes sharpen both the pitch and the company itself.
6. Ask for the real reason when investors decline
When a fundraise is not progressing as expected, founders need honest information. The polite explanation an investor provides may not be the actual reason the firm decided not to proceed. Founders should create enough trust—and demonstrate enough emotional resilience—to invite candid feedback.
The answer may be uncomfortable:
Burn is too high
Growth is too slow
Customer concentration is concerning
Churn is too high
The market appears too small
The company lacks sufficient proof of repeatability
The round expectations are disconnected from current benchmarks
Investors do not yet believe the company’s path to scale
Founders must check their egos at the door. They can hear what is comfortable, or they can work to understand what investors genuinely believe.
Not every criticism should dictate the strategy. But founders cannot respond thoughtfully to a stalled process without diagnosing why it stalled.
In some cases, the right decision may be to pause, address the underlying issue, create new proof points, and return to the market with a stronger story.
7. Build a culture capable of surviving growth
Capital allows companies to hire and scale, but rapid growth can strain the organization.
Luke highlighted three principles Redox used to preserve and strengthen its culture.
First, values must be demonstrated through decisions, particularly difficult ones. A company’s stated values mean little if they are applied only when convenient or only to junior employees.
Second, culture should be intentionally designed for the company’s next stage. Founders often romanticize the earliest days of a startup, but the goal should not be to preserve a 12-person culture indefinitely. A company at 500 people should aspire to be stronger, not merely larger, than it was at 50.
Third, companies need a talent flywheel. They should define the traits they value, assess those traits consistently during hiring, coach people effectively, and address situations where someone is no longer right for the organization.
The most difficult personnel decisions may involve people who were once excellent fits but whose needs or capabilities no longer align with the company’s direction. Avoiding those decisions can weaken talent density and undermine the values leadership claims to protect.
Building for what comes next
Venture capital can give founders the resources to pursue an ambitious vision, but capital alone does not build a successful company.
Doing so requires a credible path to scale, a willingness to confront difficult questions, and the discipline to evolve as the business grows. It also requires understanding that the decisions made during a fundraise, from accepting outside investment to selecting a board, can have lasting consequences.
As Luke's experience illustrates, the fundraising process can be an opportunity to pressure-test the strategy, clarify the company's ambitions, and build a stronger foundation for the next stage of growth.
At HealthX, we believe some of the most valuable guidance founders can receive comes from those who have already navigated these challenges. By connecting our community with experienced entrepreneurs and operators, we aim to help founders make more informed decisions as they build companies capable of creating lasting impact.
Read the first article in our series, The Art of the Fundraise: 8 Lessons from Redox Founder Luke Bonney, for Luke's practical advice on preparing for and executing a successful venture capital raise.
Photo by Mats Hagwall on Unsplash
